No Data
CHINA HEALTH INDUSTRIES HOLDNGS INC | 10-Q: Q3 2024 Earnings Report
Pacific Securities: Expanding and putting into use of hospitals “purchased” rated by Global Healthcare will bring revenue growth
According to a research report released by Pacific Securities, according to a “buy” rating for Global Healthcare (02666), the expected revenue for 2023-2025 will be 132.75/154.22/17.488 billion yuan, respectively, up 11%/16%/13% year on year; net profit to mother will be 19.52/22.5/25.32 billion yuan, respectively. The company's financial leasing business is expected to benefit from a relaxed interest rate environment, and the introduction of the hospital expansion business will also bring revenue growth. According to the report, in terms of comprehensive medical business: in terms of quantity, as of 23H1, the company had 64 medical institutions with 16,000 beds.
There is no time to delay major events such as “head” -- a healthy “smart brain” for the American year
In China, the health industry is one of the most notable industries. This also shows that Chinese people are paying more and more attention to health, yet brain health is often overlooked. According to some research, the Alzheimer's disease diagnosis market in China was about 21.75 billion yuan in 2020, and is expected to grow to 26.02 billion yuan in 2025. A series of data warns us that brain health cannot be ignored! Meinian Health Group's special brain testing product “Neorejia” has made a major breakthrough in the early detection and prediction of brain diseases. “Neoreijia” high-precision magnetic resonance imaging of the brain, using AI image analysis technology and healthy Chinese people of all ages
Unlock the Full List